Cita APA (7a ed.)

Oellerich, T., Schneider, C., Thomas, D., Knecht, K. M., Buzovetsky, O., Kaderali, L., . . . Cinatl, J. (2019). Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nature Portfolio.

Cita Chicago Style (17a ed.)

Oellerich, Thomas, et al. Selective Inactivation of Hypomethylating Agents by SAMHD1 Provides a Rationale for Therapeutic Stratification in AML. Nature Portfolio, 2019.

Cita MLA (8a ed.)

Oellerich, Thomas, et al. Selective Inactivation of Hypomethylating Agents by SAMHD1 Provides a Rationale for Therapeutic Stratification in AML. Nature Portfolio, 2019.